The German Breast Group conducts research into breast cancer, developing and implementing its own study concepts.
With the help of additional scientific research projects, we strive to gain further insights into this disease.
We are pleased to inform you that primary results from GeparX trial have been published in JAMA Oncology.
In a paper in "The Breast" we discuss the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials.
Neue Daten zum Überleben von Brustkrebspatientinnen mit Chemotherapie während der Schwangerschaft
We are happy to present our research at the ASCO Annual meeting June 2022.
We are pleased to inform you that a STEPP analysis of the updated data from the APHINITY trial has been published in European Journal of Cancer
Every month, we present an interesting paper.
We are pleased to inform you that long-term outcomes from GeparNuevo trial have been published in Annals of Oncology.